# Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations

> **NCT00387777** · PHASE1 · TERMINATED · sponsor: **Grünenthal GmbH** · enrollment: 24 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Patch with centrally acting analgesic
- **DRUG:** Transtec(R) PRO (buprenorphine)

## Key facts

- **NCT ID:** NCT00387777
- **Lead sponsor:** Grünenthal GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-10
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 24 (—)
- **Last updated:** 2016-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00387777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00387777, "Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00387777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*